lystn

Biomarkers are windows into health, like a cholesterol or PSA test. Precision medicine biomarkers enable us to refine clinical targets, and identify more precise cancer risks, diagnoses & treatments. This new health care trend translates into better cancer care & reduced collateral damage, especially for prostate cancer.

Guest: 

Jeffrey J. Tosoian, MD, MPH Assistant Professor and Director of Translational Cancer Research, Department of Urology, Vanderbilt University Medical Center, Nashville TN. Dr. Tosian’s research is focused on the development and clinical application of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide detection and management of genitourinary cancers.

Social Media

• Facebook Page: https://www.facebook.com/theoriginalguidetomenshealth/
• Twitter: https://twitter.com/guide2menshlth
• LinkedIn: https://www.linkedin.com/company/the-original-guide-to-mens-health

Resources:

• The Original Guide to Men’s Health Podcast, Episode 10. Prostate Cancer:  A) Detection, Diagnosis and PSA, B) Surveillance and Treatments.

• The Original Guide to Men’s Health Podcast Episode 43: Precision Oncology: Cancer Diagnosis and Treatment

• National Comprehensive Cancer Network— Patient Resources

• Prostate Cancer Foundation, Patient Resources

• BCAN—Bladder Cancer Advocacy Network.